Clinical Trial Update: Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury Excretion [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating transdermal absorption of DMPS and its effect on urinary mercury excretion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mercury Poisoning

Drugs mentioned

• DMPS (Dimercaptopropane-1-sulfonate) (dimercaptopropane-1-sulfonate)

Snippet

Sponsor: Banner Health | Conditions: Toxicity | Phase 1 | Status: COMPLETED